ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma.

Lin, Chao; Wu, Wen-Chuan; Zhao, Guo-Chao; Wang, Dan-Song; Lou, Wen-Hui; Jin, Da-Yong

Lin, Chao; Wu, Wen-Chuan; Zhao, Guo-Chao; Wang, Dan-Song; Lou, Wen-Hui; Jin, Da-Yong.

Affiliation

Lin C; Department of General Surgery, Zhongshan Hospital Fudan University, Shanghai, China.

Medicine (Baltimore) ; 95(31): e4527, 2016 Aug.

Article in En | MEDLINE | ID: mdl-27495108

Subject(s)

Apolipoprotein A-I/blood; Carcinoma, Pancreatic Ductal/blood; Pancreatic Neoplasms/blood; Transferrin/analysis; Biomarkers, Tumor/blood; CA-19-9 Antigen; Carcinoma, Pancreatic Ductal/mortality; Carcinoma, Pancreatic Ductal/surgery; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms/mortality; Pancreatic Neoplasms/surgery; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Transferrin / Apolipoprotein A-I / Carcinoma, Pancreatic Ductal Type of study: Observational_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2016 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google